Updated Jul 16, 2026
LEONARD JOHN M has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.15M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-27 | IQV | IQVIA HOLDINGS INC. | A — Grant or award | 1.6K | $0.00 | |
| 2026-03-03 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 156.4K | $0.00 | |
| 2026-01-07 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale | 34.1K | $9.21 | $314K |
| 2025-12-12 | NTLA | Intellia Therapeutics, Inc. | M — Option exercise [10b5-1] | 8.6K | $6.83 | $58K |
| 2025-12-12 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.4K | $9.59 | $51K |
| 2025-12-12 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 32.8K | $9.47 | $311K |
| 2025-12-12 | NTLA | Intellia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 50.0K | $9.49 | $474K |
| 2025-12-12 | NTLA | Intellia Therapeutics, Inc. | M — Option exercise [10b5-1] | 50.0K | $6.83 | $341K |
LEONARD JOHN M is a corporate insider — currently tracked as Director of IQVIA HOLDINGS INC. (IQV). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LEONARD JOHN M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.